SCHEMBL2912251

SCHEMBL2912251

C[C@@H](O)CNC(=O)c1cn(CCCNc2ccc([N+](=O)[O-])c(N)n2)cc1-c1ccc(Cl)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.40
ALDH1A1 P00352 2/20 0.40
GSK3B P49841 4/20 0.40
GSK3A P49840 3/20 0.40
CDK1 P06493 2/20 0.36
CCNB2 O95067 1/20 0.35
CCNB1 P14635 1/20 0.35
CCNB3 Q8WWL7 1/20 0.35
LMNA P02545 2/20 0.35
CYP2C19 P33261 2/20 0.33
HPGD P15428 2/20 0.33
MEN1 O00255 1/20 0.33
MITF O75030 1/20 0.33
MAPT P10636 1/20 0.33
NTSR1 P30989 1/20 0.33
KMT2A Q03164 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
HTT P42858 1/20 0.32
POLB P06746 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2904193 1.00 SMN1; SMN2 (0.40) SMN1; SMN2ALDH1A1GSK3BGSK3ACDK1
SCHEMBL2911588 0.93 ALDH1A1 (0.34) SMN1; SMN2ALDH1A1GSK3BGSK3ALMNA
SCHEMBL2911036 0.93 ALDH1A1 (0.34) SMN1; SMN2ALDH1A1GSK3BGSK3ALMNA
SCHEMBL2907242 0.92 LMNA (0.34) SMN1; SMN2ALDH1A1GSK3BGSK3ACDK1
SCHEMBL2938731 0.92 MET (0.34) SMN1; SMN2ALDH1A1GSK3BGSK3ACDK1
SCHEMBL2908179 0.92 MET (0.34) SMN1; SMN2ALDH1A1GSK3BGSK3ACDK1
SCHEMBL2904632 0.92 LMNA (0.34) SMN1; SMN2ALDH1A1GSK3BGSK3ACDK1
SCHEMBL2911017 0.92 GSK3B (0.33) SMN1; SMN2ALDH1A1GSK3BGSK3ACDK1
SCHEMBL2911391 0.92 GSK3B (0.33) SMN1; SMN2ALDH1A1GSK3BGSK3ACDK1
SCHEMBL2910075 0.91 SMN1; SMN2 (0.40) SMN1; SMN2ALDH1A1GSK3BGSK3ACDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537099-B1 PYRROLE BASED INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 NOVARTIS VACCINES & DIAGNOSTIC (US) 2010-08-11 EP disclosed